本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Solid Biosciences

9.89
+0.73007.97%
盤後9.890.00000.00%16:10 EDT
成交量:126.01萬
成交額:1,231.73萬
市值:10.60億
市盈率:-5.29
高:9.90
開:9.33
低:9.33
收:9.16
52周最高:11.45
52周最低:3.79
股本:1.07億
流通股本:6,481.19萬
量比:1.32
換手率:1.94%
股息:- -
股息率:- -
每股收益(TTM):-1.8709
每股收益(LYR):-1.9922
淨資產收益率:-65.50%
總資產收益率:-36.38%
市淨率:2.83
市盈率(LYR):-4.96

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

重要事件披露

Form 8-K - Current report
2026/03/28

SEC問詢函

Form CORRESP - Correspondence
2026/03/28

SEC問詢函

Form CORRESP - Correspondence
2026/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/06

重要事件披露

Form 8-K - Current report
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities